Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
Clinical trial NCT06802848 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06802848
- Sponsor
- Chongqing Genrix Biopharmaceutical Co., Ltd
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-30
- Primary completion
- 2026-03-31
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.